Phaco without limits

Article

Oertli is going to launch its new phaco machine CataRhex 3 on the occasion of this year?s ESCRS in Amsterdam. Never before has such cutting-edge technology been so readily and reliably available for anterior segment surgery, nor has it ever been wrapped in such compact and tempting packaging.

Phaco without Limits - Oertli launches a New Phaco Machine

Oertli is going to launch its new phaco machine CataRhex 3 on the occasion of this year's ESCRS in Amsterdam. Never before has such cutting-edge technology been so readily and reliably available for anterior segment surgery, nor has it ever been wrapped in such compact and tempting packaging.

Weighing only 5 kg, it fits into any pilot case and can be suspended from any IV pole with a simple click. CataRhex 3 is thus the epitome of a portable device. A device that takes up such little space and is so user-friendly is also becoming increasingly attractive to outpatient and high-volume clinics. A trend-setter, CataRhex 3 offers state-of-the-art surgical technologies from clear lens exchange to the hardest lenses in phaco. With HFDS ab interno, it constitutes an elegant MIGS technology in glaucoma surgery.

CataRhex 3 is a power pack incorporating cutting-edge technology. Have a look at the new CataRhex 3 by Oertli and discover the latest breathtaking functions by attending the premiere held at the ESCRS in Amsterdam at booth D06!

Company name: Oertli Instrumente AG
Address: Hafnerwisenstrasse 4, CH-9442 Berneck, Switzerland
Telephone: +41 71 747 42 00
E-mail: info@oertli-instruments.comWebsite: www. oertli-instruments.com or www. oertli-catarhex3.com

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
Related Content
© 2025 MJH Life Sciences

All rights reserved.